Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06714578

Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,035 (estimated)
Sponsor
Wei XIA, PhD · Academic / Other
Sex
All
Age
14 Years – 35 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to construct a risk tool available for screening young adults and adolescents at high risk of drug misuse and provides a chance for early intervention to young adults and adolescents at high risk of drug misuse, which prevent the onset and development of drug addiction in the future.The main question it aims to answer is: 1. Explore the occurrence and influencing factors of new psychoactive substance misuse among young adults and adolescents; 2. Construct a risk prediction model for new psychoactive substance misuse among young adults and adolescents and conduct internal verification of the model; 3. Based on the results of the prediction model, select the optimal model to initially form a concise scale "Screening Tool for the Risk of New Psychoactive Substance Misuse among Young Adults and Adolescents"; 4. Conduct external verification of the tool, and revise and improve the screening tool, form the final version of the screening tool, and verify the application performance of the screening tool.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire and Physical ExamThe investigators use questionnaire to assess biological factors (sleep quality, externalizing problem behavior, prosocial tendencies, sensation seeking, and hedonic hunger), psychological factors (risk awareness of drug misusing, indulgence of drug misusing, self-efficacy of drug misusing, and ACEs), and social factors (whether work in a special place, whether have drug-addicts around, cognition of traditional drug types, and cognition of NPS types) and demographic data

Timeline

Start date
2024-12-15
Primary completion
2025-08-15
Completion
2025-12-01
First posted
2024-12-03
Last updated
2024-12-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06714578. Inclusion in this directory is not an endorsement.